Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Abstract BackgroundThis study identified factors associated with hospital admission among people with laboratory-diagnosed COVID-19 cases in British Columbia. MethodsThis study was performed using the BC COVID-19 Cohort, which integrates data on all COVID-19 cases, hospitalizations, medical visits, emergency room visits, prescription drugs, chronic conditions and deaths. The analysis included all laboratory-diagnosed COVID-19 cases in British Columbia as of January 15th, 2021. We evaluated factors associated with hospital admission using multivariable Poisson regression analysis with robust error variance. FindingsFrom 56,874 COVID-19 cases included in the analyses, 2,298 were hospitalized. Models showed significant association of the following factors with increased hospitalization risk: male sex (adjusted risk ratio (aRR)=1.27; 95%CI=1.17-1.37), older age (p-trend <0.0001 across age groups with a graded increase in hospitalization risk with increasing age [aRR 30-39 years=3.06; 95%CI=2.32-4.03, to aRR 80+years=43.68; 95%CI=33.41-57.10 compared to 20-29 years-old]), asthma (aRR=1.15; 95%CI=1.04-1.26), cancer (aRR=1.19; 95%CI=1.09-1.29), chronic kidney disease (aRR=1.32; 95%CI=1.19-1.47), diabetes (treated without insulin aRR=1.13; 95%CI=1.03-1.25, requiring insulin aRR=5.05; 95%CI=4.43-5.76), hypertension (aRR=1.19; 95%CI=1.08-1.31), injection drug use (aRR=2.51; 95%CI=2.14-2.95), intellectual and developmental disabilities (aRR=1.67; 95%CI=1.05-2.66), problematic alcohol use (aRR=1.63; 95%CI=1.43-1.85), immunosuppression (aRR=1.29; 95%CI=1.09-1.53), and schizophrenia and psychotic disorders (aRR=1.49; 95%CI=1.23-1.82). Among women of reproductive age, in addition to age and comorbidities, pregnancy (aRR=2.69; 95%CI=1.42-5.07) was associated with increased risk of hospital admission. InterpretationOlder age, male sex, substance use, intellectual and developmental disability, chronic comorbidities, and pregnancy increase the risk of COVID-19-related hospitalization. FundingBC Centre for Disease Control, Canadian Institutes of Health Research. Research in contextEvidence before this studyFactors such as older age, social inequities and chronic health conditions have been associated to severe COVID-19 illness. Most of the evidence comes from studies that don’t include all COVID-19 diagnoses in a jurisdiction), focusing on in-hospital mortality. In addition, mental illness and substance use were not evaluated in these studies. This study assessed factors associated with hospital admission among people with laboratory-diagnosed COVID-19 cases in British Columbia.Added value of this studyIn this population-based cohort study that included 56,874 laboratory-confirmed COVID-19 cases, older age, male sex, injection drug use, problematic alcohol use, intellectual and developmental disability, schizophrenia and psychotic disorders, chronic comorbidities and pregnancy were associated with the risk of hospitalization. Insulin-dependent diabetes was associated with higher risk of hospitalization, especially in the subpopulation younger than 40 years. To the best of our knowledge this is the first study reporting this finding, (insulin use and increased risk of COVID-19-related death has been described previously).Implications of all the available evidencePrioritization of vaccination in population groups with the above mentioned risk factors could reduce COVID-19 serious outcomes. The findings indicate the presence of the syndemic of substance use, mental illness and COVID-19, which deserve special public health considerations.
McKee Geoffrey、Vel¨¢squez Garc¨aa H¨|ctor Alexander、Galanis Eleni、Rose Caren、Krajden Mel、Wilton James、Chong Mei、David Samara、Rasali Drona、Smolina Kate、Janjua Naveed Zafar、Otterstatter Michael、Prystajecky Natalie
British Columbia Centre for Disease ControlBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control||Department of Pathology and Laboratory Medicine, University of British ColumbiaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease ControlCentre for Immunization and Respiratory Infectious Diseases, Public Health Agency of CanadaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British Columbia||Centre for Health Evaluation and Outcome Sciences, St Paul?ˉs HospitalBritish Columbia Centre for Disease Control||School of Population and Public Health, University of British ColumbiaBritish Columbia Centre for Disease Control
医学研究方法医药卫生理论内科学
McKee Geoffrey,Vel¨¢squez Garc¨aa H¨|ctor Alexander,Galanis Eleni,Rose Caren,Krajden Mel,Wilton James,Chong Mei,David Samara,Rasali Drona,Smolina Kate,Janjua Naveed Zafar,Otterstatter Michael,Prystajecky Natalie.Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study[EB/OL].(2025-03-28)[2025-08-02].https://www.medrxiv.org/content/10.1101/2021.08.26.21262697.点此复制
评论